Genistein preserved the beneficial central effects of Δ9-THC without psychiatric side effects in vivo,1 which suggest that CB1 antagonist genistein has clinically significant and would be promising therapeutics for atherosclerosis treatment. The gene discussed is CNR1; the disease is atherosclerosis.